Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Targeted Oncology|June 21, 2015
Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-AnalysisGaetan Des Guetz, Thierry Landre, Bernard Uzzan, et al.
Pituitary|November 7, 2015
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's diseaseMaria Fleseriu, Rosario Pivonello, Jacques Young, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2009
Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysisGaëtan Des Guetz, Olivier Schischmanoff, Patrick Nicolas, et al.
Anticancer Research|May 16, 2009
Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysisGaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, et al.
European Journal of Radiology|September 28, 2011
Patterns of pulmonary tuberculosis on FDG-PET/CTMichael Soussan, Pierre-Yves Brillet, Arsène Mekinian, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2010
Wnt/β-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and -nonsecreting tumorsStéphane Bonnet, Sébastien Gaujoux, Pierre Launay, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancyFlorence de Fraipont, Michelle El Atifi, Nadia Cherradi, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2015
Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD)Delphine Vezzosi, Florence Tenenbaum, Laure Cazabat, et al.
Annals of Surgery|December 25, 2007
Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumorsPatsy S H Soon, Rossella Libe, Diana E Benn, et al.
European Journal of Endocrinology|July 4, 2025
Progression of potentially aggressive pituitary neuroendocrine tumors after radiotherapy: risk factors, management, and outcomesFabio Bioletto, Caroline Bogeat, Maxime Barat, et al.
Pageof 14